Actos Lawsuit News(02/17/2012) Actos Lawsuit: Persons suffering due to an Actos injury need the counsel of skilled attorneys who will inform them on the complexities of their case and lead them through the legal system. Actos is used with diet and exercise programs to treat Type II Diabetes. In 2011, the U.S. Food and Drug Administration (FDA) released an ongoing safety review regarding a potential risk of bladder cancer when you take Actos. Tell your healthcare provider right away if you have any of the following symptoms of bladder cancer: blood or a red color in your urine, an increased need to urinate, or pain while you urinate. If you have suffered this type of Actos Injury, our purpose is to help you receive the financial compensation you deserve so you don’t have to worry about your medical costs. Call Best Legal Source at 800-611-7080 or complete the contact form to the right and we will put you in touch with an experienced Actos Injury attorney who will discuss your potential Actos Injury lawsuit.
Actos Lawsuit: Anyone who has been prescribed Actos and been diagnosed with bladder cancer may have an Actos Injury claim. An update from the FDA states that use of the drug Actos for more than one year may be associated with an increased risk of bladder cancer. This information is being added to the Warning and Precautions section of the medication label along with revision of the Medication Guide. If you have suffered an Actos Injury, you need attorneys with a proven track record. For more information contact Best Legal Source today.
Actos Lawsuit, Actos Injury and Actos Injury Attorney are general terms used to describe the health related issues associated with the medication Actos. The use of these terms, or any other phrase containing the word Actos, does not imply any connection or relationship between the makers of Actos and Best Legal Source. Our website is intended to assist individuals who believe their injuries were a direct result of taking the drug Actos.
When scheduling a consultation with an Actos Injury attorney, you will want a group of lawyers experienced in dealing with Actos Injury lawsuits and similar cases. We recognize the life changing impact an Actos Injury can have. If you or a loved one has suffered from taking Actos, we will connect you with Actos Injury attorneys to help you receive the financial compensation you need for your medical costs as well as physical and emotional pain. Call Best Legal Source today!
Actos Lawsuit News 2/17/2012: Please contact us today if you took Actos and suffered unusual side effects or other injuries.
Actos Lawsuit: Cancer cells can spread throughout the body. They can spread through the lymphatic system, composed of lymph channels and lymph nodes, or distantly to other organs or the skeleton via the blood stream (hematogenous spread). In the case of bladder cancer, the cells can also spread by being carried in the urine and implanting in other locations in the urinary tract.
The pathologist studies the prepared slides and makes a determination of the grade of cancer. There are a number of criterions that are used: degree of cellularity, nuclear crowding, loss of polarity and differentiation, nuclear pleomorphism, chromatin pattern and mitotic activity. In layman’s terms, the pathologist looks at the size, shape and relationship of the cancer cells. The nucleus is often abnormal since it contains damaged or mutated DNA. Cancer cells look different than normal cells. The greater the difference from normal, the higher the grade will be. These parameters are utilized to reduce the subjective nature of pathology.
If a urine dipstick is positive for blood, it is recommended to check the urine under a microscope. The urine is first spun down to separate out the sediment and is then examined under the high power lens. If there are more than 3 red blood cells per high power field it is felt to be significant. If there are no other reasons for the presence of blood such as a urinary infection, the urine should be rechecked. If there is a persistent presence of significant microscopic hematuria, an assessment is recommended. When there is a large amount of microscopic hematuria, especially in older individuals with risk factors for bladder cancer, there is no need to repeat the urinalysis as a workup should be done.
Actos Lawsuit: Additional Information and Resources
Actos Lawsuit: Cystoscopy (examination of the bladder) is usually the first step in making the diagnosis of bladder cancer. Given the signs and symptoms suggesting bladder cancer, or an X ray or ultrasound revealing a possible bladder tumor, cystoscopy is a must. Cystoscopy can be accomplished with either a flexible cystoscope or a rigid scope. The flexible cystoscope is composed of small optical fibers encased by a plastic sheath. A rigid scope has glass lenses within a metal sheath. Both cystoscopes are passed directly through the urethra into the bladder to visualize the inside surface. Cystoscopy can be accomplished in both the urologist’s office or as an outpatient at a hospital or surgicenter.
The flexible cystoscope is easier and less painful to pass, especially for males whose urethra is longer and more tortuous than in females. Flexible cystoscopy is readily accomplished in the doctor’s office. A lubricant is applied to the scope to ease passage. Local anesthesia can be squirted into the urethra prior to passing the scope. Discomfort from the cystoscope is usually well tolerated and short in duration. The discomfort usually lasts a few seconds as the scope is passed through the prostate. At that time, you may feel a pressure sensation. In females, passage of the scope is quick and relatively painless.
If you are being initially screened for asymptomatic microscopic hematuria, a urologist will often choose flexible cystoscopy as the first step. He is not certain whether or not you have a bladder cancer or other condition causing the hematuria. Flexible cystoscopy will provide that answer in a less time consuming, less painful and more cost effective way than rigid cystoscopy. On the other hand, if there is a high likelihood a tumor is present, it makes sense to do rigid cystoscopy and if required, resection all at one setting.
Because a positive cytology is very specific for cancer, it is highly predictive of transitional cell cancer even if no tumor is visible during cystoscopy. Additional information can be obtained with urine cytology. The DNA content and measurement of the amount of abnormal DNA can be determined. In general, as the amount of abnormal DNA is increased, the prognosis is worsened.
When an individual has gross hematuria or persistent microscopic hematuria, a complete assessment of the urinary tract is required. Although cystoscopy is the test of choice for examination of the bladder, imaging studies are required to make sure there is no disease in the upper tracts (kidneys and ureters). Bleeding can be caused from many different disorders including transitional cell carcinoma of the upper tracts, kidney or ureteral stones, or renal cell carcinoma (cancer of the parenchyma or fleshy part of the kidneys). Your urologist has a number of options to choose from. There are advantages and disadvantages of each.
Actos Lawsuit: News and Information from related Sources
Actos Lawsuit: CT Scan or CAT (computerized axial tomography) provides a computerized cross sectional visualization of the abdomen and pelvis. X ray images are synthesized into exquisitely detailed images. The CT scan can be done with or without IV contrast, and therefore has the same limitations as IVP in those with allergies to contrast or renal insufficiency. These studies are excellent for finding renal cell cancers and stones within the kidneys and ureter, but not very good at delineating cancers of the lining. CT scan is often an important part of staging bladder cancer, determining whether the cancer has spread.
Magnetic Resonance Imaging (MRI) is a technology which uses strong magnets to provide detailed images of your internal organs. Like ultrasound, this study has no known harmful effects on the body. It does not require contrast injection like CT scan and can be done safely in patients with renal insufficiency. It is not generally used for initial screening. Many individuals find the test uncomfortable due to a loud noise heard throughout the test, in addition to the close quarters the machine requires, leading to feelings of claustrophobia.
Initial treatment may eradicate an individual’s bladder cancer, however, for many, recurrent tumors may develop. Up to 70% of individuals will have recurrent bladder cancer after initial therapy. In approximately one third of patients, not only will tumors recur, but they will become more serious over time, developing a higher grade or stage. This chapter will review the importance of staging bladder cancer, the single most important predictor of future problems. In addition, we will review other important indicators that impact the prognosis.
In the case of bladder cancer, initial stage is critical in predicting the prognosis. For individuals with bladder cancer, recurrence (repeated tumors) is common. For many, progression (the development of higher grade, invasive or metastatic cancer) is also a real concern. By looking at the initial stage of the bladder cancer and restaging with each new cancer recurrence, the urologist can predict or prognosticate the possibility of the individual developing more life threatening invasive disease which has the ability to spread beyond the bladder and lead to death. Treatment options exist at each stage of cancer. It is the goal of the urologist to preserve your bladder as long as possible without jeopardizing your life with a cancer that may spread and become incurable.
Actos Lawsuit: Information and News
Actos Lawsuit: Most individuals with bladder cancer will undergo an initial removal of their bladder tumor by biopsy or for larger tumors by resection of their tumor via a resectoscope. For complete details see Chapter 8. Once this tumor is removed, the pathologist will determine and report on the extent of tumor invasion into the wall of the bladder. If the tumor has grown into the prostate, tissue removal via the resectoscope from this location will also be reviewed and reported pathologically. This pathologic diagnosis determines the initial stage of the cancer.
Once an individual develops bladder cancer, there is a high likelihood that even after removal of the cancer, recurrence will occur. Depending on the initial presentation, some 60-90% will at some time experience recurrent disease. Due to the high recurrence rate, bladder cancer is the second most prevalent cancer in middle aged and elderly men. Recurrence requires repeated endeavors at tumor removal and the possibility of adding other treatment regimens, which can be time consuming, costly and emotionally and physically challenging.
In some individuals recurrence is also accompanied by progres¬sion, the development of higher grade, invasive bladder cancer with the propensity to spread and possibly take the life of the individual. For many individuals with low stage, low grade disease, recurrences may be minimal and progression almost nil. For those with more intermediate grade and stage, there exists a higher recurrence and progression rate.
Carcinoma in situ (CIS or Tis): although these “flat” tumors are confined to the most superficial layer, they are generally multi¬focal, high grade and have a high likelihood of invasion with a substantial risk for cancer death. They may appear as red velvety or granular areas, or may not be visible through the cystoscope, but are found on random biopsy. CIS will usually result in an abnormal cytology. If an individual has diffuse CIS with irritative symptoms, progression to invasive disease can be expected in up to 80%. For those with only focal CIS, without symptoms, progression occurs in less than 10%. In a recent series from the Mayo Clinic, the rate of progression per year was 4% . When CIS is associated with even low grade, early stage bladder cancers, progression is seen in over 80%, similar to those with diffuse, symptomatic CIS. When CIS is found in conjunction with superficial bladder cancer, the prognosis is markedly worsened.
Our use of the term or terms Actos Lawsuit is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.
To keep up to date on Actos Lawsuit News visit our site often.